Keywords: Johnson & Johnson, Scios, Natrecor, Pfizer, Inspra, American Heart Association meeting

Heart meeting hears disappointing results for J&J/Scios Natrecor; strong findings for Pfizer’s Inspra

Article | 15 November 2010

Print This

Studies presented at the American Heart Association conference taking place in Chicago, showed that people with mild heart failure lived ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in